Omics and AI advance biomarker discovery for liver disease
- PMID: 35710988
- DOI: 10.1038/s41591-022-01853-9
Omics and AI advance biomarker discovery for liver disease
Comment on
-
Noninvasive proteomic biomarkers for alcohol-related liver disease.Nat Med. 2022 Jun;28(6):1277-1287. doi: 10.1038/s41591-022-01850-y. Epub 2022 Jun 2. Nat Med. 2022. PMID: 35654907 Free PMC article.
References
-
- GBD 2017 Cirrhosis Collaborators. Lancet Gastroenterol. Hepatol. 5, 245–266 (2020). - DOI
-
- Singal, A. K. & Mathurin, P. J. Am. Med. Assoc. 326, 165–176 (2021). - DOI
-
- Niu, L. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01850-y (2022). - DOI - PubMed
-
- Ahn, J. C. et al. Hepatology 73, 2546–2563 (2021). - DOI
-
- Yip, T. C. et al. Aliment. Pharmacol. Ther. 46, 447–456 (2017). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
